Startups
-
Bio Startup Tisento Launches With $81M and a Brain-Penetrating Drug in the Clinic
A Phase 2b-ready Cyclerion Therapeutics drug candidate for a rare mitochondrial disease gets new life under a new startup led by a familiar face. Tisento Therapeutics acquired the Cyclerion drug and is backed by a Series A round financing.
-
RapidAI Rakes In $75M to Accelerate Stroke Diagnosis
RapidAI recently closed a $75 million Series C funding round led by Vista Credit Partners. The company offers an AI platform that helps hospital care teams triage and treat stroke patients more quickly.
-
Healthcare VC Jumpstart Foundry Now Accepting Applications for Fall Funding
Early-stage healthcare innovation fund Jumpstart Foundry is accepting Fall funding applications through September 30th. Read on to find out why Jumpstart Foundry could be the missing piece in your startup’s journey to making a lasting difference in healthcare.
-
Bio Startup Nexo Lands $60M to Climb to New Heights in Cancer Drug R&D
Nexo Therapeutics is developing cancer drugs that expand the scope of amino acids addressable by covalent chemistry. Versant Ventures founded the startup and led its Series A financing.
-
NorthShore Study Proves Hospitals Can Save Millions by Providing Post-Discharge Psychosocial Support
NorthShore University HealthSystem teamed up with Laguna Health in 2021 to study whether greater post-acute care support can improve patient recovery and reduce readmissions. The research partners recently released results of the study, which found that giving patients emotional and psychological support after their discharge hastens recovery, decreases costs and alleviates physician burnout.
-
Sanofi Puts Up $125M to Partner on Oral Drug That Could Be Dupixent’s Successor
Sanofi is interested in Recludix Pharma’s approach to treating inflammation with an oral small molecule that targets a protein thought to be undruggable. If it works, the drug could have safety and dosing advantages over currently available biologic drugs, including blockbuster Sanofi drug Dupixent.
-
What Misconceptions Does the Healthcare Industry Still Have About Home-Based Care?
The at-home care field holds significant market potential. As the subsector continues to grow, some leaders of home healthcare startups are challenging misconceptions that some other industry stakeholders may still have, including the misbelief that at-home care is only for senior citizens and that this care model lacks scalability.
-
Startup Tenpoint Lands $70M to Bring Vision-Restoring Cell Therapy to the Eye
Tenpoint Therapeutics’ name refers to the time it takes for an image to hit the retina and be processed by the brain. The regenerative medicine startup is developing cell therapies it hopes restore that vision capability for patients with degenerative eye disorders.
-
Devices & Diagnostics, Startups
French Startup Snags $14M for Prenatal Ultrasound AI Tool
Sonio recently gained $14 million in Series A funding. The Paris-based startup’s AI platform automates ultrasound reporting so that healthcare providers can conduct ultrasound exams with greater accuracy, speed and efficiency.
-
RA Capital Leads $150M Financing for Septerna and Lead Drug With Oral Edge in Rare Hormone Disease
Septerna Therapeutics’ Series B financing will support plans to reach the clinic with a pill for a rare disease whose only approved therapy is a Takeda Pharmaceutical drug that’s leaving the market. Potential rival therapies are all injectables.
-
Devices & Diagnostics, Health Tech, Startups
Swedish Startup Snags $65M for Scanning Tech Designed to Facilitate Earlier Disease Detection
Neko Health recently raised €60 million (about $65.8 million) in Series A financing. The Stockholm-based startup’s medical scanning technology aims to conveniently and affordably collect extensive health data to aid doctors in catching diseases early. The company’s scan takes about 10 minutes and costs €250 (about $275).
-
Pharma, BioPharma, Health Tech
Women’s Health Startups Graduate from PharmStars Digital Health Accelerator
A new cohort of startups has graduated from PharmStars, a digital health accelerator. This latest group focused on women’s health and health equity.
-
UCSF Spinout Raises $12M for Platform That Facilitates Secure AI Development
BeeKeeperAI — which offers a platform to facilitate the development and deployment of healthcare AI models — raked in $12.1 million in Series A funding led by Santé Ventures. The startup was spun out of UCSF last year.
-
DexCare Rakes In $75M to Optimize Health Systems’ Digital Care Management
Providence spinout DexCare recently closed a $75 million Series C funding round, bringing its total funding to date to $146 million. The startup gives health systems a platform that helps them coordinate and manage digital care services so they can better address the modern healthcare consumer’s demands for convenience and immediacy.
-
Pharma, Artificial Intelligence, BioPharma
Flagship Startup Emerges to Find Drugs in Promising Hunting Ground—Our Bodies
Scientists at Empress Therapeutics say molecules that co-evolved with humans over millennia are a promising source of new drugs. With its AI-driven technology platform, the Flagship Pioneering-founded startup finds them.
-
Meet Zuri — The Startup That Just Launched to Help People Navigate Infertility
A new startup named Zuri Fertility recently launched. Its platform provides resources for patients who are trying to conceive — including telehealth, at-home testing, prescriptions, mental health services, education and care coordination.